Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias Lutz

Showing results (61-70 of 90) with videos related to

Pageof 9
Sort By:
Acta Ophthalmologica|September 14, 2012
N-chlorotaurine and its analogues N,N-dichloro-2,2-dimethyltaurine and N-monochloro-2,2-dimethyltaurine are safe and effective bactericidal agents in ex vivo corneal infection modelsBarbara Teuchner, Christian Eitzinger, Matthias Lutz, et al.
Cardiovascular Therapeutics|July 7, 2016
Preprocedural but not periprocedural high-sensitive Troponin T levels predict outcome in patients undergoing transcatheter aortic valve implantationWiebke M Köhler, Sandra Freitag-Wolf, Moritz Lambers, et al.
Open Heart|August 2, 2017
Osteopontin predicts clinical outcome in patients after treatment of severe aortic stenosis with transcatheter aortic valve implantation (TAVI)Matthias Lutz, Nora von Ingersleben, Moritz Lambers, et al.
Critical Care (London, England)|June 27, 2015
Persistently elevated osteopontin serum levels predict mortality in critically ill patientsChristoph Roderburg, Fabian Benz, David Vargas Cardenas, et al.
Circulation. Cardiovascular Interventions|June 11, 2019
Clinical and Angiographic Outcomes With a Novel Radiopaque Sirolimus-Eluting Bioresorbable Vascular ScaffoldBernard Chevalier, Alexandre Abizaid, Didier Carrié, et al.
JACC. Cardiovascular Interventions|September 23, 2017
6-Month Clinical and Angiographic Outcomes of a Novel Radiopaque Sirolimus-Eluting Bioresorbable Vascular Scaffold: The FANTOM II StudyAlexandre Abizaid, Didier Carrié, Norbert Frey, et al.
Journal of Thrombosis and Thrombolysis|January 11, 2017
Development of a new catheter prototype for laser thrombolysis under guidance of optical coherence tomography (OCT): validation of feasibility and efficacy in a preclinical modelRouven Berndt, Rene Rusch, Lars Hummitzsch, et al.
Wiener Medizinische Wochenschrift (1946)|May 10, 2021
A Choosing Wisely top-5 list to support general practitioners in AustriaAnna Glechner, Susanne Rabady, Herbert Bachler, et al.
Frontiers in Cardiovascular Medicine|February 26, 2024
Fractional flow reserve measurements and long-term mortality-results from the FLORIDA studyFelicitas Boeckling, Barbara E Stähli, Tanja Rudolph, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|April 2, 2024
Long-term safety and effectiveness of the Fantom bioresorbable coronary artery scaffold: final results of the FANTOM II trialMatthias Lutz, Alexandre Abizaid, Emil Nielsen Holck, et al.
Pageof 9

Showing results (61-70 of 90) with videos related to

Sort By:
Pageof 9
Acta Ophthalmologica|September 14, 2012
N-chlorotaurine and its analogues N,N-dichloro-2,2-dimethyltaurine and N-monochloro-2,2-dimethyltaurine are safe and effective bactericidal agents in ex vivo corneal infection modelsBarbara Teuchner, Christian Eitzinger, Matthias Lutz, et al.
Cardiovascular Therapeutics|July 7, 2016
Preprocedural but not periprocedural high-sensitive Troponin T levels predict outcome in patients undergoing transcatheter aortic valve implantationWiebke M Köhler, Sandra Freitag-Wolf, Moritz Lambers, et al.
Open Heart|August 2, 2017
Osteopontin predicts clinical outcome in patients after treatment of severe aortic stenosis with transcatheter aortic valve implantation (TAVI)Matthias Lutz, Nora von Ingersleben, Moritz Lambers, et al.
Critical Care (London, England)|June 27, 2015
Persistently elevated osteopontin serum levels predict mortality in critically ill patientsChristoph Roderburg, Fabian Benz, David Vargas Cardenas, et al.
Circulation. Cardiovascular Interventions|June 11, 2019
Clinical and Angiographic Outcomes With a Novel Radiopaque Sirolimus-Eluting Bioresorbable Vascular ScaffoldBernard Chevalier, Alexandre Abizaid, Didier Carrié, et al.
JACC. Cardiovascular Interventions|September 23, 2017
6-Month Clinical and Angiographic Outcomes of a Novel Radiopaque Sirolimus-Eluting Bioresorbable Vascular Scaffold: The FANTOM II StudyAlexandre Abizaid, Didier Carrié, Norbert Frey, et al.
Journal of Thrombosis and Thrombolysis|January 11, 2017
Development of a new catheter prototype for laser thrombolysis under guidance of optical coherence tomography (OCT): validation of feasibility and efficacy in a preclinical modelRouven Berndt, Rene Rusch, Lars Hummitzsch, et al.
Wiener Medizinische Wochenschrift (1946)|May 10, 2021
A Choosing Wisely top-5 list to support general practitioners in AustriaAnna Glechner, Susanne Rabady, Herbert Bachler, et al.
Frontiers in Cardiovascular Medicine|February 26, 2024
Fractional flow reserve measurements and long-term mortality-results from the FLORIDA studyFelicitas Boeckling, Barbara E Stähli, Tanja Rudolph, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|April 2, 2024
Long-term safety and effectiveness of the Fantom bioresorbable coronary artery scaffold: final results of the FANTOM II trialMatthias Lutz, Alexandre Abizaid, Emil Nielsen Holck, et al.
Pageof 9